CompaniesOcteta Therapeutics

Octeta Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

210

By Phase

NA: 1

By Status

ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT05135052
Hover over trial bars to see details

Recent Trials

NCT05135052Lead Sponsor
Rhenium-Skin Cancer Therapy (SCT) for the Treatment of Non-Melanoma Skin Cancer.
NAActive, not recruiting
210 participants
Started: Jan 17, 2022 · Completed: May 15, 2027
Funding History (1)
D
May 19, 2016
Filing